News Image

Top S&P500 movers in Thursday's session

By Mill Chart

Last update: Sep 22, 2022

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Today's top gainers

TickerChangeComment
LLY4.64%ELI LILLY & CO's (NYSE:LLY) stock price is advancing with 4.64% to a price of $310.25. In the last year the share price increased with 27.97%.
MRK3.9%MERCK & CO. INC.'s (NYSE:MRK) shares rose 3.9% to $87.83. Earlier today the company had a press release: Merck Animal Health to Acquire Vence.
BMY2.98%BRISTOL-MYERS SQUIBB CO's (NYSE:BMY) shares rose 2.98% to $71.53 during Thursday's session.
ABBV2.47%ABBVIE INC (NYSE:ABBV) rose 2.47% to $143.78 during Thursday's after hours session. Shareholders saw the stock price going 31.05% higher is the past year.
VRTX2.37%VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) rose 2.37% to $287.04 during Thursday's after hours session. Shareholders saw the stock price going 52.72% higher is the past year.
VLO2.19%VALERO ENERGY CORP's (NYSE:VLO) stock price is advancing with 2.19% to a price of $107.84. Shareholders saw the stock price going 56.04% higher is the past year.
SLB2.13%SCHLUMBERGER LTD's (NYSE:SLB) stock price increased by 2.13% to $38.38. Earlier today the company had a press release: Schlumberger Awarded Energy Data Project from Wintershall Dea.
JNJ2.06%JOHNSON & JOHNSON's (NYSE:JNJ) stock price is advancing with 2.06% to a price of $166.64.
ATVI1.86%ACTIVISION BLIZZARD INC's (NASDAQ:ATVI) stock price increased by 1.86% to $76.72.
VZ1.81%VERIZON COMMUNICATIONS INC's (NYSE:VZ) stock price increased by 1.81% to $40.2. In the last 3 months the stock lost 22.53%.

For the full top gainers list go to our top gainers screener.

Losers

TickerChangeComment
CZR-10.98%CAESARS ENTERTAINMENT INC's (NASDAQ:CZR) shares fell 10.98% to $36.98 during Thursday's session. In the last 6 months the stock lost 46.33%.
PENN-8.72%PENN ENTERTAINMENT INC's (NASDAQ:PENN) shares fell 8.72% to $26.6 during Thursday's session. In the last 6 months the share price dropped with 29.82%.
FDS-7.76%FACTSET RESEARCH SYSTEMS INC's (NYSE:FDS) stock price decreased by 7.76% to $397.04. FACTSET RESEARCH SYSTEMS INC released earnings Yesterday.
ENPH-7.46%ENPHASE ENERGY INC's (NASDAQ:ENPH) stock price is declining with 7.46% to a price of $281.82. In the last 3 months the share price increased with 53.52%.
MGM-7.18%MGM RESORTS INTERNATIONAL's (NYSE:MGM) stock price is declining with 7.18% to a price of $30.43. Yesterday the company had a press release: Two Fun Stocks The Insiders Are Buying.
EXPE-6.97%EXPEDIA GROUP INC's (NASDAQ:EXPE) shares fell 6.97% to $92.11 during Thursday's session. The stock is trading 48.48% lower than 6 months ago.
WYNN-6.9%WYNN RESORTS LTD's (NASDAQ:WYNN) shares fell 6.9% to $59.58 during Thursday's session. Shareholders saw the stock price going 20.28% lower is the past 6 months.
AMD-6.68%ADVANCED MICRO DEVICES's (NASDAQ:AMD) shares fell 6.68% to $69.5 during Thursday's session. The stock is trading 37.76% lower than 6 months ago.
ETSY-6.62%ETSY INC's (NASDAQ:ETSY) stock price is declining with 6.62% to a price of $97.19. In the last 3 months the share price increased with 24.46%.
SEDG-6.07%SOLAREDGE TECHNOLOGIES INC's (NASDAQ:SEDG) shares fell 6.07% to $270.49 during Thursday's session.

For the full top loser list go to our top losers screener.

Back

VERTEX PHARMACEUTICALS INC

NASDAQ:VRTX (4/24/2024, 7:00:03 PM)

After market: 404 +3.24 (+0.81%)

400.76

-4.15 (-1.02%)

VRTX News

News Image10 hours ago - TreeFrog TherapeuticsVERTEX UND TREEFROG THERAPEUTICS GEBEN LIZENZVEREINBARUNG UND ZUSAMMENARBEIT ZUR OPTIMIERUNG DER PRODUKTION DER ZELLTHERAPIEN VON VERTEX FÜR TYP-1-DIABETES BEKANNT

/PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) und TreeFrog Therapeutics gaben heute bekannt, dass Vertex eine exklusive Lizenz für...

News Image16 hours ago - The Motley FoolMissed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

News Image2 days ago - TreeFrog TherapeuticsVertex y Treefrog Therapeutics anuncian un acuerdo para la producción de las terapias celulares de Vertex

/PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) y TreeFrog Therapeutics anunciaron hoy que Vertex obtuvo una licencia exclusiva para la...

News Image2 days ago - The Motley FoolVertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Vertex is broadening its portfolio.

News Image2 days ago - Yahoo FinanceVertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Vertex is broadening its portfolio.

News Image2 days ago - TreeFrog TherapeuticsVERTEX TREEFROG THERAPEUTICS CONCLUT UN ACCORD STRATEGIQUE ET DE LICENCE AVEC L'AMERICAIN VERTEX PHARMACEUTICALS POUR OPTIMISER LA PRODUCTION DE THERAPIES CELLULAIRES DANS LE DIABETE DE TYPE 1

/PRNewswire/ -- TreeFrog Therapeutics annonce aujourd'hui que Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) a obtenu une licence exclusive de C-Stem™, la...

News Image2 days ago - TreeFrog TherapeuticsVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

/PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to...

News Image2 days ago - TreeFrog TherapeuticsVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

/CNW/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to...

News Image3 days ago - The Motley FoolMaking Sense of Amazon CEO Andy Jassy's Latest Letter

And that's just part of the interesting news for investors to dig into.

News Image3 days ago - The Motley FoolIf You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today

Could Vertex's growth story continue?

News Image3 days ago - The Motley FoolLooking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now

These stocks could be near major inflection points.

News Image4 days ago - The Motley Fool2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever

These stocks probably won't be getting much cheaper.

VRTX Links
Follow us for more